NCLT: Suspended Directors Who are Prospective Resolution Applicants Cann’t Access Valuation Reports  ||  Supreme Court Clarifies Test For Granting Bail to Accused Added at Trial under Section 319 CrPC  ||  SC: Fresh Notification For Vijayawada ACB Police Station not Required After AP Bifurcation  ||  SC: Studying in a Government Institute Does Not Create an Automatic Right to a Government Job  ||  NCLT Mumbai: CIRP Claims Cannot Invoke the 12-Year Limitation Period For Enforcing Mortgage Rights  ||  NCLAT: Misnaming Guarantor as 'Director' in SARFAESI Notice Doesn't Void Guarantee Invocation  ||  Jharkhand HC: Mere Breach of Compromise Terms by an Accused Does Not Justify Bail Cancellation  ||  Cal HC: Banks Cannot Freeze a Company's Accounts Solely Due To ROC Labeling a 'Management Dispute'  ||  Rajasthan HC: Father’s Rape of His Daughter Transcends Ordinary Crime; Victim’s Testimony Suffices  ||  Delhi HC: Judge Who Reserved Judgment Must Deliver Verdict Despite Transfer; Successor Can't Rehear    

SC: Drugs (Price Control) Order, 1995 Cannot be Subjected to Restricted or Hidebound Interpretation - (19 Jul 2024)

LAW OF MEDICINE

SC held that intent of Drugs (Price Control) Order is to control prices at which medicinal drug formulations are made available, by holding out threat of recovery of higher prices charged for such formulations. Considering the objective of the provision, it cannot be interpreted in restriction.

Tags : SUPREME COURT   MEDICINAL DRUG FORMULATIONS   HIGHER PRICES  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved